Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.450
-0.070 (-4.61%)
Jun 10, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $133.22 million as of June 10, 2026. Its market cap has increased by 114.34% in one year.
Market Cap
133.22M
Enterprise Value
79.44M
1-Year Change
114.34%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $133.22M, an increase of 161.08%. That is a compound annual growth rate of 22.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 139.66M | 3.40% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spero Therapeutics | 148.81M |
| Molecular Partners AG | 143.54M |
| Corbus Pharmaceuticals Holdings | 142.66M |
| AN2 Therapeutics | 140.74M |
| NRx Pharmaceuticals | 140.08M |
| ADC Therapeutics | 139.91M |
| Spruce Biosciences | 134.94M |
| Jyong Biotech | 134.36M |